Canaccord Genuity analyst Maria Ripps raised her price target for Hims & Hers Health (NYSE: HIMS) to $68.00, up from […]
Hims & Hers (NYSE: HIMS) Stock Gets Major Price Target Upgrade Read More »
Hims & Hers Health (NYSE: HIMS) stock surged about 20% on Wednesday following the announcement of its acquisition of Trybe
Hims & Hers Health (NYSE: HIMS) Stock Surges Following Trybe Labs Acquisition Read More »
On Tuesday, Zimmer Biomet (NYSE: ZBH) said it would acquire medical device company Paragon 28 (NYSE: FNA) for about $1.1
Zimmer Biomet to Acquire Paragon 28 in $1.1 Billion Deal Read More »
The U.S. FDA has approved Novo Nordisk’s (NYSE: NVO) Ozempic for reducing the risk of kidney failure and disease progression,
The cyberattack at UnitedHealth Group’s (NYSE: UNH) tech unit last year affected the personal information of 190 million people, the
UnitedHealth Says Tech Unit Hack Affected 190 Million People Read More »
On Friday, the U.S. Centers for Medicare and Medicaid Services said it would not appeal a court order that it
US Drops Appeal in Case Over UnitedHealth Medicare Plans’ Rating Read More »
On Thursday, UnitedHealth Group (NYSE: UNH) named Tim Noel, the head of its Medicare business, to the top job at
UnitedHealth Taps Insider to Replace Slain Executive as CEO of Insurance Unit Read More »
On Wednesday, Abbott Laboratories (NYSE: ABT) forecast 2025 profit that came in line with Wall Street estimates as it expects
Abbott Banks on Glucose Monitors, New Launches to Ride Out China, Currency Hit Read More »
Johnson & Johnson (NYSE: JNJ), fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular (NASDAQ: ITCI), reported fourth-quarter
Johnson & Johnson Beats Q4 Sales and Profit Estimates on Cancer Drug Sales Read More »
Copyright © 2025 abbonews.com
